Cargando…
Meta-analyses of FibroTest diagnostic value in chronic liver disease
BACKGROUND: FibroTest (FT) is a biomarker of liver fibrosis initially validated in patients with chronic hepatitis C (CHC). The aim was to test two hypotheses, one, that the FT diagnostic value was similar in the three other frequent fibrotic diseases: chronic hepatitis B (CHB), alcoholic liver dise...
Autores principales: | Poynard, Thierry, Morra, Rachel, Halfon, Philippe, Castera, Laurent, Ratziu, Vlad, Imbert-Bismut, Françoise, Naveau, Sylvie, Thabut, Dominique, Lebrec, Didier, Zoulim, Fabien, Bourliere, Marc, Cacoub, Patrice, Messous, Djamila, Munteanu, Mona, de Ledinghen, Victor |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2175505/ https://www.ncbi.nlm.nih.gov/pubmed/17937811 http://dx.doi.org/10.1186/1471-230X-7-40 |
Ejemplares similares
-
Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C
por: Poynard, Thierry, et al.
Publicado: (2004) -
Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease
por: Ratziu, Vlad, et al.
Publicado: (2006) -
Intra-individual fasting versus postprandial variation of biochemical markers of liver fibrosis (FibroTest) and activity (ActiTest)
por: Munteanu, Mona, et al.
Publicado: (2004) -
Applicability and precautions of use of liver injury biomarker FibroTest. A reappraisal at 7 years of age
por: Poynard, Thierry, et al.
Publicado: (2011) -
An Accurate Definition of the Status of Inactive Hepatitis B Virus Carrier by a Combination of Biomarkers (FibroTest-ActiTest) and Viral Load
por: Ngo, Yen, et al.
Publicado: (2008)